Abstract: Systems and methods for managing use of a pharmaceutical product (112) are provided. The systems and methods utilize an external cover (150) and a container (110), along with a first material (160) and a pharmaceutical product (112) that are each contained within an internal space (116) that exists when the external cover (150) is in a closed position relative to the container (110). Release of the first material (160) may bond the external cover (150) to the container (110), may result in the first material (160) coming into contact with the pharmaceutical product (112), or both.

Abstract: A container (100) for storing transdermal patches is disclosed. The container (100) includes a child-resistant mechanism (112) to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism (112) may include first and second access components (116, 120) that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components (116, 120) in a particular manner allows the container (100) to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components (116, 120) may be simultaneously engaged (e.g., depressed) to open the container (100). In another arrangement, the first and second access components (116, 120) may be engaged in series in a particular sequence to open the container (100).

Abstract: Systems and methods for monitoring a container (180) for storing a pharmaceutical product (190) are presented. The container (180) may be monitored (210) such that container movement may be detected (212) and logic may be provided for determining if the movement was authorized. In the event of unauthorized movement, an alarm (140) may be activated (214) to alert a user or stakeholder of the unauthorized movement. The movement of the pharmaceutical product container (180) may be detected by way of a motion sensor (120) such as an accelerometer. The alarm (140) may comprise an auditory or visual alarm as well as a network communication indicative of the activation of an alarm. The alarm (140) may be prevented or canceled (218).

Abstract: Systems and methods for tracking dosage periods are disclosed. The systems and methods may include setting a timer (140) to a predetermined value corresponding to a dosage period in response to the engagement of a cover (110) to a container (120). An indication may be provided that corresponds to a remaining period in the dosage period set by the engagement of the cover (110) and container (120). The indication may also indicate a remaining time period in the dosage period.

Abstract: Containers and methods for disposing unused pharmaceutical product are disclosed. Each container (100, 200, 300) may include a container body (104, 204, 304) with an internal chamber (116, 216, 316) for storing pharmaceutical product, along with a cover (124, 224, 324) for selectively limiting access to the chamber (116, 216, 316). An encapsulation component (128, 228, 328) may be selectively disposable within the chamber (116, 216, 316), and may be operable to encapsulate the pharmaceutical product within the container (100, 200, 300). For instance, the encapsulation component (128, 228, 328) may melt and/or flow into contact with the pharmaceutical product and thereafter solidify to encapsulate the pharmaceutical product. The encapsulation component (128, 228, 328) may melt and thereafter solidify between the cover (124, 224, 324) and shell (104, 204, 304) to limit removal of the cover (124, 224, 324) from the shell (104, 204, 304).

Abstract: A medical fluid delivery system (300) includes workflow construction logic (304) to create one or more workflows (307) from a plurality of available workflow components (306). The created workflows (307) may each contain a proper subset of workflow components from the plurality of available workflow components (306). The workflows (307) may be created using the workflow construction logic (304) and a user interface (302) by selecting and arranging graphical elements representing workflow components (306). The constructed workflows (307) may correspond with the practices of a given care group. The medical fluid delivery system (300) may further include workflow execution logic (305) operable to execute the workflows (307). When executed, the workflows (307) may sequentially guide a user through each of the included workflow components (306) using a fled interface. The nomenclature displayed by the workflow components (306) during workflow execution may be customizable.

Abstract: A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes.

Abstract: A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes.

Abstract: A contrast media injection system includes detects the absolute position of the syringe ram using a non-contact sensor. A series of magnets and Hall-Effect sensors may be used or an opto-reflective system. Illuminated knobs that are connected to the drive mechanism for the syringe ram rotate with the drive and provide visual feedback on operation through the illumination. Analog Hall-Effect sensors are used to determine the presence or absence of magnets that identify the type of faceplate being used. The faceplates include control electronics, connected to the powerhead through connectors, which may be interchangeably used by the two faceplates. The faceplate electronics include detectors for automatically detecting the capacity of pre-filled syringes.

Abstract: A power injector and a removable replacement faceplate therefor are provided along with a method of front loading syringes, particularly prefilled syringes, which have outwardly extending structure such as flanges which have been typically breech loaded or side loaded into injectors or operated in a hand held fashion. The holder or faceplate of or for the injector is provided with a set of jaws spaced around a syringe receiving opening into which a syringe is loaded, rearward end first, with the jaws in a retracted position, until the flange or other outwardly extending structure on the syringe is rearward of the syringe is beyond a locking position of the jaws. The jaws are then actuated, either by operating an actuator on the faceplate or injector or by twisting the syringe in the opening, so that the jaws move radially inward and close in iris-like fashion about the syringe.

Abstract: A power injector is provided for injecting fluid from a replaceable syringe and through an injection tube into the body of an animal. The syringe includes one or more operator-removable and interchangeable syringe mounting heads, at least one of which mounts syringes of a rear loadable type. Preferably an alternative head is provided that accepts front loadable syringes. The mounting head includes an opening and a moveable syringe holder that preferably pivots open to receive a syringe from the back of the holder and pivots closed to orient the rear of the syringe over the ram. The holder has a slot therethrough having a width sufficient to permit an injection tube attached to the syringe nozzle to be moved transversely through the slot to permit the syringe to be removed from the holder without disconnecting the tube from the orifice of the syringe and without withdrawing the tip of the tube rearwardly through the opening.

Abstract: A power injector is provided for injecting fluid from a replaceable syringe into the body of an animal. The syringe includes a syringe adapter interface for accepting side mountable syringes having pushrod extensions for actuating the syringe plungers from a point behind the syringe body. The injector is provided with an operator-removable and interchangeable interface in the form of a syringe mounting head. The interface includes a holder that has two halves, one fixed and one moveable, that open and close in a clam-shell fashion to respectively load or unload a syringe and to operate the syringe by driving the plunger thereof with a power driven ram that extends form the injector housing. The end of the injector ram, which is configured to normally couple to a button or key on the back of the plunger of a front or rear loadable syringe, is provided with an adapter that couples to the ram and to the large disk shaped end of a side loadable syringe pushrod.